These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 25384772)

  • 1. Black Molds and Melanized Yeasts Pathogenic to Humans.
    Chowdhary A; Perfect J; de Hoog GS
    Cold Spring Harb Perspect Med; 2014 Nov; 5(8):a019570. PubMed ID: 25384772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dematiaceous fungi.
    Revankar SG
    Mycoses; 2007 Mar; 50(2):91-101. PubMed ID: 17305771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanized fungi in human disease.
    Revankar SG; Sutton DA
    Clin Microbiol Rev; 2010 Oct; 23(4):884-928. PubMed ID: 20930077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous infections due to opportunistic molds: uncommon presentations.
    Vennewald I; Wollina U
    Clin Dermatol; 2005; 23(6):565-71. PubMed ID: 16325064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indoor wet cells as a habitat for melanized fungi, opportunistic pathogens on humans and other vertebrates.
    Wang X; Cai W; van den Ende AHGG; Zhang J; Xie T; Xi L; Li X; Sun J; de Hoog S
    Sci Rep; 2018 May; 8(1):7685. PubMed ID: 29769615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi.
    Brandt ME; Warnock DW
    J Chemother; 2003 Nov; 15 Suppl 2():36-47. PubMed ID: 14708965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. North American dimorphic fungal infections in children.
    Montenegro BL; Arnold JC
    Pediatr Rev; 2010 Jun; 31(6):e40-8. PubMed ID: 20516233
    [No Abstract]   [Full Text] [Related]  

  • 8. Emerging fungal pathogens.
    Anaissie EJ; Bodey GP; Rinaldi MG
    Eur J Clin Microbiol Infect Dis; 1989 Apr; 8(4):323-30. PubMed ID: 2497012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis.
    Müller FM; Seidler M
    Expert Rev Anti Infect Ther; 2010 Aug; 8(8):957-64. PubMed ID: 20695750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and antifungal susceptibility of fungi isolated from dermatomycoses.
    Silva LB; de Oliveira DB; da Silva BV; de Souza RA; da Silva PR; Ferreira-Paim K; Andrade-Silva LE; Silva-Vergara ML; Andrade AA
    J Eur Acad Dermatol Venereol; 2014 May; 28(5):633-40. PubMed ID: 23556501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic approaches to subcutaneous mycoses.
    Koga T; Matsuda T; Matsumoto T; Furue M
    Am J Clin Dermatol; 2003; 4(8):537-43. PubMed ID: 12862496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of infections caused by dematiaceous fungi.
    Revankar SG
    Expert Rev Anti Infect Ther; 2005 Aug; 3(4):601-12. PubMed ID: 16107199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunistic filamentous mycoses: aspergillosis, mucormycosis, phaeohyphomycosis and hyalohyphomycosis.
    Perusquía-Ortiz AM; Vázquez-González D; Bonifaz A
    J Dtsch Dermatol Ges; 2012 Sep; 10(9):611-21; quiz 621-2. PubMed ID: 22925358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternaria infections: laboratory diagnosis and relevant clinical features.
    Pastor FJ; Guarro J
    Clin Microbiol Infect; 2008 Aug; 14(8):734-46. PubMed ID: 18727797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous mycoses in coastal Karnataka in south India.
    Bhat RM; Monteiro RC; Bala N; Dandakeri S; Martis J; Kamath GH; Kambil SM; Asha Vadakayil R
    Int J Dermatol; 2016 Jan; 55(1):70-8. PubMed ID: 26267755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fungal Musculoskeletal Infections.
    Henry MW; Miller AO; Walsh TJ; Brause BD
    Infect Dis Clin North Am; 2017 Jun; 31(2):353-368. PubMed ID: 28483045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and management of fungal infections in immunocompromised patients.
    Venkatesan P; Perfect JR; Myers SA
    Dermatol Ther; 2005; 18(1):44-57. PubMed ID: 15842612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging subcutaneous mycoses by opportunistic filamentous fungi: A retrospective study in Northwest Spain.
    Taibo A; Seoane Estévez A; Martínez Campayo N; Rodríguez Mayo M; Arévalo Bermúdez MDP; Fonseca E
    Mycoses; 2023 Oct; 66(10):891-897. PubMed ID: 37381098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terbinafine: broad new spectrum of indications in several subcutaneous and systemic and parasitic diseases.
    Pérez A
    Mycoses; 1999; 42 Suppl 2():111-4. PubMed ID: 10865916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Black fungi: clinical and pathogenic approaches.
    De Hoog GS; Queiroz-Telles F; Haase G; Fernandez-Zeppenfeldt G; Attili Angelis D; Gerrits Van Den Ende AH; Matos T; Peltroche-Llacsahuanga H; Pizzirani-Kleiner AA; Rainer J; Richard-Yegres N; Vicente V; Yegres F
    Med Mycol; 2000; 38 Suppl 1():243-50. PubMed ID: 11204152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.